Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique
- 25 June 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 95 (8) , 996-1004
Abstract
Background: Intrapleural fluid infusion improves ultrasonographic visualization of tumours in the hepatic dome. The aim of this study was to assess the safety and long‐term efficacy of ultrasonographically guided percutaneous radiofrequency ablation for tumours in the hepatic dome with intrapleural infusion. Methods: Of 2575 patients with hepatocellular carcinoma or hepatic metastases treated with radiofrequency ablation, intrapleural fluid infusion was performed in 587 patients for tumours in the hepatic dome. After the tip of a 14‐G metallic needle was positioned in the pleural cavity under ultrasonographic guidance, 500–1000 ml of 5 per cent glucose solution was infused in 5–15 min. Radiofrequency ablation was performed using an internally cooled electrode. Long‐term results were evaluated in 347 patients with a single hepatocellular carcinoma who were naive to any treatment. Results: Intrapleural fluid infusion was successfully performed in all 587 patients. The major complication rate on a per tumour basis was similar for patients treated with and without intrapleural infusion (1·6 versus 1·6 per cent; P = 0·924). The overall and recurrence‐free survival were both similar for naive patients with a single hepatocellular carcinoma treated with and without intrapleural infusion (P = 0·429 and P = 0·109 respectively). Intrapleural infusion was not associated with lower overall survival in multivariable analysis. Conclusion: With intrapleural fluid infusion, radiofrequency ablation for tumours in the hepatic dome was safe and effective, resulting in satisfactory overall and recurrence‐free survival. Copyright © 2008 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.Keywords
This publication has 15 references indexed in Scilit:
- A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular CarcinomaGastroenterology, 2005
- Percutaneous radiofrequency ablation for hepatocellular carcinomaCancer, 2005
- Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablationGastroenterology, 2004
- Transthoracic Percutaneous Radiofrequency Ablation for Liver Tumors in the Hepatic DomeJournal of Vascular and Interventional Radiology, 2004
- Percutaneous Sonographically Guided Radiofrequency Ablation with Artificial Pleural Effusion for Hepatocellular Carcinoma Located Under the DiaphragmAmerican Journal of Roentgenology, 2004
- Percutaneous Radiofrequency Ablation Guided by Contrast-Enhanced Harmonic Sonography with Artificial Pleural Effusion for Hepatocellular Carcinoma in the Hepatic DomeAmerican Journal of Roentgenology, 2004
- Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic domeJournal of Gastroenterology, 2003
- Percutaneous radiofrequency ablation of liver metastases in potential candidates for resectionCancer, 2003
- Small Hepatocellular Carcinoma: Treatment with Radio-frequency Ablation versus Ethanol InjectionRadiology, 1999
- Percutaneous microwave coagulation therapy with intraperitoneal saline infusion for hepatocellular carcinoma in the hepatic dome.American Journal of Roentgenology, 1999